Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ultragenyx Pharmaceutical

35.29
-0.0800-0.23%
Volume:373.70K
Turnover:13.05M
Market Cap:3.26B
PE:-5.61
High:35.47
Open:34.36
Low:34.29
Close:35.37
Loading ...
Feb 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 22, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Oct 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 23, 2023

Major Issues Report

Form 8-K - Current report
Oct 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 19, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Oct 16, 2023

Major Issues Report

Form 8-K - Current report
Sep 12, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Sep 08, 2023

Major Issues Report

Form 8-K - Current report
Sep 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 04, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Jul 12, 2023

Major Issues Report

Form 8-K - Current report
Jul 06, 2023

Major Issues Report

Form 8-K - Current report